General Information
Revision date
2023-06-28
Product name
Fluvastatin sodium salt, HMG-CoA reductase inhibitor
Substance name
Pure substance/mixture
CAS No.
93957-55-2
1.2.1 Relevant identified uses
For research use only. Not for use in diagnostic procedures
Icons in SDS
Company Information
company name
Abcam Australia Pty. Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
au.technical@abcam.com, sds@abcam.com
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H302, H351, H360
Hazard statements
Code
Statements
H302
Harmful if swallowed
H351
Suspected of causing cancer
H360
May damage fertility or the unborn child
Section 2
SECTION 2: Hazards identification
GHS Classification Acute toxicity - Oral Category 4 - (H302) Carcinogenicity Category 2 - (H351) Reproductive toxicity Category 1A - (H360) Label elements Exclamation mark
Signal word
DANGER Hazard statements H302 - Harmful if swallowed H351 - Suspected of causing cancer H360 - May damage fertility or the unborn child Precautionary Statements - Prevention Obtain special instructions before use Do not handle until all safety precautions have been read and understood Wear protective gloves/clothing and eye/face protection Wash face, hands and any exposed skin thoroughly after handling Do not eat, drink or smoke when using this product Precautionary Statements - Response IF exposed or concerned: Get medical advice/attention IF SWALLOWED: Call a POISONS CENTRE or doctor if you feel unwell Rinse mouth Precautionary Statements - Storage Store locked up
Precautionary statements
Disposal Dispose of contents/container to an approved waste disposal plant
Other hazards which do not result in classification
Caution - substance not yet tested completely.
2.1 Classification of the substance or mixture
Category 4 - (H302) Carcinogenicity Category 2 - (H351) Reproductive toxicity Category 1A - (H360) Label elements